Offer - Urjas Oil for just ₹ 1 X
Rosofibric is a prescription drug, available for use as Capsule. The alternative uses of Rosofibric have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Rosofibric. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Rosofibric also has some side effects, the most common being Nausea or vomiting, Headache, Constipation. While these are the most often observed Rosofibric side effects, there are can be others also. These have been listed below. Such side effects of Rosofibric normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Rosofibric's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Rosofibric's effects on the liver, heart and kidney are discussed below in the Rosofibric related warnings section.
Rosofibric can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rosofibric in conditions like Diabetes.
Additionally, Rosofibric may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Rosofibric is not safe while driving, and is is not addictive in nature.
Rosofibric is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosofibric safe for pregnant women?
Rosofibric can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Rosofibric right away. Take your doctor's advice before taking it again.
Is the use of Rosofibric safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Rosofibric. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Rosofibric on the Kidneys?
Rosofibric rarely harms the kidneys.
What is the effect of Rosofibric on the Liver?
Very few cases of side effects of Rosofibric on the liver have been reported.
What is the effect of Rosofibric on the Heart?
Rosofibric may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Rosofibric should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rosofibric unless your doctor advises you to do so -
Is this Rosofibric habit forming or addictive?
No, there is no any evidence that Rosofibric is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rosofibric you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Rosofibric only on doctor's advice.
Is it able to treat mental disorders?
No, Rosofibric is not used to treat mental disorders.
Interaction between Food and Rosofibric
Information is not available on the interaction of any foods with Rosofibric, due to a lack of research on this.
Interaction between Alcohol and Rosofibric
No research has been done on this till date. Therefore, it is not known what the effect of taking Rosofibric with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650